Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+56.7Malignant Bladder Neoplasm+23.3Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+16.7Malignant Vulvar Neoplasm+13.4Malignant Pancreatic Neoplasm+10Malignant Vaginal Neoplasm+10Malignant Kidney Neoplasm+6.6Malignant Esophageal Neoplasm+3.4Malignant Mesothelioma+3.3Malignant Liver Neoplasm0Malignant Lung Neoplasm0Malignant Prostate Neoplasm0Malignant Rectal Neoplasm0Malignant Salivary Gland Neop…0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+56.7100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
42361
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
96.7
activityPercentile
40

ranking row 2600959

2=Malignant Bladder Neoplasm+23.396.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
16254
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
70
activityPercentile
46.7

ranking row 2600960

3=Cutaneous Melanoma+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8885
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2600961

4=Malignant Laryngeal Neoplasm+16.790Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3763
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
36.7
activityPercentile
20

ranking row 2600962

5=Malignant Vulvar Neoplasm+13.486.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1127
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
26.7
activityPercentile
13.3

ranking row 2600963

6=Malignant Pancreatic Neoplasm+1083.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41615
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
90
activityPercentile
80

ranking row 2600964

6=Malignant Vaginal Neoplasm+1083.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
438
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
10
activityPercentile
0

ranking row 2600965

8=Malignant Kidney Neoplasm+6.676.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14448
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
63.3
activityPercentile
56.7

ranking row 2600966

9=Malignant Esophageal Neoplasm+3.473.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
15211
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
66.7
activityPercentile
63.3

ranking row 2600967

10=Malignant Mesothelioma+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2404
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2600968

11=Malignant Liver Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
25760
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
83.3
activityPercentile
83.3

ranking row 2600971

11=Malignant Lung Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
153718
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2600969

11=Malignant Prostate Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
28848
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
86.7
activityPercentile
86.7

ranking row 2600972

11=Malignant Rectal Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10035
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2600974

11=Malignant Salivary Gland Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
993
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
16.7
activityPercentile
16.7

ranking row 2600970

11=Malignant Testicular Neoplasm066.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
374
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
6.7
activityPercentile
6.7

ranking row 2600973

17=Malignant Thyroid Gland Neoplasm-3.346.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1894
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
30
activityPercentile
33.3

ranking row 2600975

18=Malignant Anal Neoplasm-3.343.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1014
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
20
activityPercentile
23.3

ranking row 2600976

19=Malignant Breast Neoplasm-3.440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41986
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2600977

19=Malignant Central Nervous System Neoplasm-3.440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
16268
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
73.3
activityPercentile
76.7

ranking row 2600978

21=Malignant Hypopharyngeal Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
369
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
3.3
activityPercentile
10

ranking row 2600979

21=Malignant Penile Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
301
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2600980

23=Leukemia-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
22847
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
90

ranking row 2600981

23=Malignant Ovarian Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13920
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
60
activityPercentile
70

ranking row 2600982

23=Malignant Uterine Corpus Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4350
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
43.3
activityPercentile
53.3

ranking row 2600983

26=Hodgkin Lymphoma-13.416.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1120
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
23.3
activityPercentile
36.7

ranking row 2600984

27=Malignant Gastric Neoplasm-13.413.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11330
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
53.3
activityPercentile
66.7

ranking row 2600985

28=Multiple Myeloma-16.610Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12231
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
56.7
activityPercentile
73.3

ranking row 2600986

28=Non-Hodgkin Lymphoma-16.610Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
20154
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
76.7
activityPercentile
93.3

ranking row 2600987

30=Malignant Cervical Neoplasm-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4175
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
40
activityPercentile
60

ranking row 2600988

31=Malignant Nasopharyngeal Neoplasm-300Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
709
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
13.3
activityPercentile
43.3

ranking row 2600989

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 2a118d5c900d6a45b93a49e9